Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Gynecol Oncol. 2022 Apr 7;165(3):437–445. doi: 10.1016/j.ygyno.2022.03.020

Table 3:

Association between pre-diagnosis smoking and overall survival (to 5 years) among women with ovarian cancer, by germline BRCA status: MAYO, SEARCH and validation set (MAYO/SEARCH) pooled analysis

MAYOa SEARCHa Validation set pooled analysis
BRCA carrier BRCA non-carrier BRCA carrier BRCA non-carrier BRCA carrier BRCA non-carrier
N HRa (95% CI) N HRa (95% CI) pb N HRa (95% CI) N HRa (95% CI) pb pHR (95% CI) pHR (95% CI)
Never smoked 115 1.00 726 1.00 0.3 62 1.00 425 1.00 0.6 1.00 1.00
Ever smoked 65 1.44 (0.88-2.36) 445 1.07 (0.90-1.26) 39 0.77 (0.28-2.11) 291 1.13 (0.87-1.48) 1.24 (0.73-2.09) 1.09 (0.94-1.25)
 Former 50 1.34 (0.77-2.32) 354 1.08 (0.91-1.30) 27 0.59 (0.18-1.91) 205 1.26 (0.95-1.67) 1.06 (0.51-2.19) 1.13 (0.97-1.31)
 Current 15 1.75 (0.83-3.70) 91 1.00 (0.74-1.37) 12 1.80 (0.35-9.31) 86 0.82 (0.51-1.32) 1.76 (0.89-3.47) 0.94 (0.73-1.22)

Abbreviations: CI = confidence interval, HR = hazard ratio, pHR = pooled hazard ratio.

a

MAYO and SEARCH models were adjusted for age, BMI, year of diagnosis and stratified by stage.

b

p-value for the interaction between the variable and BRCA status, in the model stratified by BRCA status.